The effect of haemodilution on coagulation has been extensively investigated. We investigated auto-haemodilution following a 10% blood loss (480 ml) and its effect on coagulation.
The enhanced coagulation effects of haemodilution have been demonstrated, both in vitro 1,2 and in vivo 3, 4 in tests using the thrombelastograph (TEG) and in other tests. Haemodilution also causes an increase in platelet aggregability, and a significant decrease in anti-thrombin III (ATIII) concentration of whole blood 3 . Janvrin et al reported increased deep venous thrombosis (DVT) rates with crystalloid haemodilution 5 , and Heather et al reported the "saline predictor test"-the probability of patients developing a postoperative DVT 6 . These observations suggest that haemodilution per se, rather than the diluents used, enhances the coagulability of whole blood. In a recent clinical study Ng et al demonstrated that haemodilution causes enhanced coagulation, when compared to no dilution, in patients after anaesthesia, but before the commencement of surgery 7 .
With haemodilution, the naturally occurring activated circulating anticoagulants, like antithrombin III (ATIII), are diluted or consumed. However, the haemodilution has no effect on the spontaneous formation of activated thrombin, even though the prothrombin is diluted equivalently, as activated thrombin makes up only a minute fraction of the total prothrombin 8 . This imbalance between coagulants and anticoagulants leads to a state of relative hypercoagulability, as evidenced by thrombelastography (TEG). This suggests a dynamic "activation" of the coagulation cascade after haemodilution.
This in vivo study was designed to investigate the rate of autodilution with interstitial space fluid and the potential pro-coagulant effect of haemodilution when a unit of blood (approximately 500 ml or 10% of the circulation) was taken from volunteers.
METHODS
This experiment was approved by the Research Ethics Committee of the Western Province Blood Transfusion Service (WPBTS). Ten healthy volunteers, all regular blood donors, with a body weight of 55-85 kg (~4000-6000 ml of circulating blood volume) were enrolled. Exclusion was based on the local blood transfusion service donation guidelines and the taking of any anticoagulant, aspirin, anti-inflammatory or procoagulant drugs. Informed written consent was obtained from all volunteers prior to participation. The volunteers were admitted unstarved to the WPBTS in the morning and were requested to drink 200 ml of fluid prior to commencement of the trial, 500 ml in the first hour after donation, 200 ml in the second hour, and 100 ml per hour thereafter until six hours had elapsed.
The effect on coagulability was measured by the TEG, while the time over which the autodilution occurred was measured by the reduction in haematocrit.
A baseline fresh whole blood sample was taken for TEG, ATIII and fibrinogen levels and catecholamine assays (heparinized samples, immediately centrifuged at 4000 rpm for 10 minutes, then plasma frozen at -70°C for batching). A full blood count, including haematocrit, was taken prior to blood donation being commenced. Thereafter, a standard unit of blood (approximately 500 ml or ~8.3-12.5% of total blood volume) was taken according to WPBTS guidelines. All ten donations were made within 15 minutes, and a second blood sample was then taken immediately post donation, and the same tests were performed. These tests were repeated at 1, 2, 4 and 6 hours post blood donation. All samples were taken by twosyringe technique from a free-flowing vein in the forearm, each sampling site more distal to any previous venous puncture site.
ATIII was measured using an IL Test™ antithrombin Kit (20008900-Instrumentation Laboratory Company, Lexington, MA). The IL antithrombin kit is an assay based on synthetic chromogenic substrate and on Factor Xa inactivation. Fibrinogen was measured using an IL Test™ PT-Fibrinogen Recombinant kit (20005000-Instrumentation Laboratory Company, Lexington, MA). This test is based on a combined assessment of the prothrombin time and fibrinogen level by the addition of recombinant rabbit thromboplastin to the plasma. The fibrinogen is quantified by relating the absorbance or light scatter during clotting to a calibrator. The full blood count was performed using an Advia (Bayer Instruments), which also provided a five-point differential. Manual review of all abnormal flags was performed.
Plasma catecholamine concentrations were measured by electrochemical detection after separation with reverse phase high pressure liquid chromatography using dihydrobenzylamine as the internal standard. The coefficient of variation was 7.9% for noradrenaline, 8.7% for adrenaline and the limit of sensitivity was 20 pg.ml -1 .
Data were analysed using analysis of variance for repeated measures, with post hoc least significant difference testing, using Statistica for Windows Release 5.5 (StatSoft 2000) . Using a P value of 0.05 as significant, the study had power of 90% to detect a 20% difference in coagulation parameters.
RESULTS
There was a significant decrease in r-time in the sample taken immediately post blood donation compared to the control sample. This value returned to baseline at 1 hour post donation and did not change further. There were no significant changes in any other TEG variables (Table 1) . Antithrombin III (ATIII) and fibrinogen levels did not show any differences from control ( Table 2) .
Fractional plasma noradrenaline changes were significantly raised at 1 hour post donation (P=0.048), with a trend observed immediately post donation (P=0.18). The raised noradrenaline levels returned to baseline at 2 hours post donation (Figure 1 ). Adrenaline concentrations were below the lower level of sensitivity of the method throughout the trial.
The haematocrit showed a rapid (~4%) fall during donation, followed by a slow but progressive continued decrease over six hours, falling by a mean of 8.3% from pre-donation values. This reduction in haematocrit from zero baseline, displayed a trend in the immediate post donation samples (P=0.053), and was significantly decreased from one hour post donation (P≤0.05) ( Figure 2 ).
DISCUSSION
A significant shortening of r-time compared to control occurred in the post donation sample, with a trend towards significance in the other TEG variables (shortened k-time, increased alpha angle and maximum amplitude) suggesting enhancement of the onset of coagulation and a trend towards hypercoagulability: these returned to baseline from 1 hour post donation. There was no significant hypercoagulability after the initial blood loss had occurred. The shortened r-time was not related to how the sample was taken. The coagulation effects of an indwelling cannula per se, have been documented by Gorton et al 9 .
Previously research using the TEG reflected enhanced coagulability following haemodilution, and decreased levels of antithrombin III and fibrinogen (a larger fall than explained by dilution alone) in volunteers undergoing in vivo haemodilution with both crystalloids and colloids 3 . In this study, the faster onset of coagulation after donation of the blood returned to normal by one hour, while the noradrenaline levels remained raised until two hours post donation, with plasma adrenaline remaining unmeasurable throughout. This probably reflects an increase in vascular tone after a rapid 10% loss of circulating blood volume, rather than purely a sympathetic stress response. It argues against the concept that catecholamines make a major contribution to the observed enhancement of coagulation after haemodilution. However, it is important to note that the rate of decrease in haematocrit is greatest in the 15 minutes during which the blood is being lost, especially when compared to the reduction over the first hour post donation, and over subsequent twohour periods. One can speculate that, as a result of the immediate rapid dilution, enhanced coagulation results; and then, as the vascular tone increases, dilution and the enhancement of coagulation slows. It must be noted that, while a lowering of haematocrit is reported to reduce coagulation on the basis of decreased blood viscosity leading to a faster arterial blood flow 8 , this does not affect the microvascular circulation where coagulation is less dependent on the viscosity of blood.
Indeed, our expectation of progressive hypercoagulability due to continuing autodilution was not seen in this study. There are two possible explana- tions for autodilution not producing ongoing enhancement of coagulation. The explanation that the phenomenon of haemodilution-induced enhanced coagulability may be the consequence of introduction of foreign material into the blood is unlikely, because enhanced coagulation has been seen to occur with a wide range of materials of different biochemical composition. Although the former cannot be entirely excluded, the far more likely explanation is that the rate of dilution may be too slow and too small after the initial dilution to create the necessary dynamic imbalance. As seen in our results above, ATIII and fibrinogen levels did not change in this study. It would thus appear that autodilution of blood to replace the 10% loss does not induce major hypercoagulability after the initial rapid response. A reason may be that, as the total dilution is only 8.3% occurring over six to eight hours, an imbalance between anticoagulants and spontaneously activated coagulants required for the enhancement of coagulation 8 is not precipitated. This contrasts with the case following a rapid, large volume (20-30%) haemodilution 7 . We have previously suggested that the rate of infusion, rather than the infusion per se will change the coagulability 11 .
On the other hand, it is of interest that a 10% loss of blood volume in a healthy donor is easily compensated for by the sympathetic response, through an increase in the tone of blood vessels secondary to rising noradrenaline concentration, while the adrenaline concentration remains unchanged. During blood donation some subjects experience stress reactions. However, the frequency of these reactions is higher in first-time donors than in experienced ones, with increased cortisol levels observed before a first donation, but not among experienced donors. Blood donation per se is not a stressful event and moderate stress, as suggested by increased cortisol levels and heart rate at the first donation, is secondary to emotional rather than to physical stimuli 12 . In determining the relative roles of autonomic regulation and hormones during blood donation, Fortrat et al 13 found that blood donation led to increases in the plasma catecholamines and an increase in systolic blood pressure. Heart rate, cardiovascular variability and the spontaneous baroreflex sensitivity did not change.
Seen in the light of enhanced coagulation after haemodilution 1-5, 14-17 and the minimal autonomic changes we observed in healthy blood donors, one may reflect on the thoughts of Janvrin et al about the "myth that dehydration and haemoconcentration are risk factors in DVT; it is rather the intravascular infusions which should be avoided" 18 .
